High expression of PKM2 synergizes with PD-L1 in tumor cells and immune cells to predict worse survival in human lung adenocarcinoma
Long Long(Integrated Chinese Medicine (China)), Honglei Chen(Central South University)
Cited by 24
Related Papers
Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet Neurology|2017|2.3k
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
|The Lancet|2017|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Update of the MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2019|760
Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease
|Archives of Neurology|2003|635